and could be even better when they combine it with folfirinox study.
not sure if it’s just me but this company seems to fly under the radar a bit. Looked at verastem website and they’ve got a good investigator sponsored trial programme, about half their current trials are IST. It’s a great way to seed your assets with clinicians , raise profile, get future investigators on board at very low cost (often drug cost only)
and could be even better when they combine it with folfirinox...
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
